Dr Lalchandani Labs is currently trading at Rs. 17.94, up by 2.99 points or 20.00% from its previous closing of Rs. 14.95 on the BSE.
The scrip opened at Rs. 14.55 and has touched a high and low of Rs. 17.94 and Rs. 14.55 respectively. So far 36000 shares were traded on the counter.
The BSE group 'M' stock of face value Rs. 10 has touched a 52 week high of Rs. 25.75 on 27-Nov-2018 and a 52 week low of Rs. 11.00 on 22-Oct-2019.
Last one week high and low of the scrip stood at Rs. 17.94 and Rs. 13.00 respectively. The current market cap of the company is Rs. 7.77 crore.
The promoters holding in the company stood at 60.78%, while Non-Institutions held 39.22% stake in the company.
Dr Lalchandani Labs has commenced its business operations in more well-known cities Hyderabad and Bangalore starting from the month of October 2019, to meet the growing demand of the market and for serving more people. This new business expansion will offer an extensive range of growth in the company.
Dr Lalchandani Labs is formed to set up, engage, collaborate, acquire, purchase, maintain, open collection centres, conduct, manage, administer, own, run laboratories for the purposes of carrying out pathological investigations of various branches of Bio-Chemistry, Hematology, Histopathology, Microbiology, Electrophoresis, Virology, Cytology, other pathological Investigations and Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA & Genetic Testing etc.